Get started
AFT PHARMACEUTICALS LIMITEDAFT PHARMACEUTICALS LIMITEDAFT PHARMACEUTICALS LIMITED

AFT PHARMACEUTICALS LIMITED

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

AFP chart


Full chart

AFP upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪251.62 M‬ AUD
Dividend yield (indicated)
0.60%
Price to earnings Ratio (TTM)
18.25
Basic EPS (TTM)
0.14 AUD
Net income (FY)
‪14.31 M‬ AUD
Revenue (FY)
‪179.11 M‬ AUD
Shares float
‪28.38 M‬
Beta (1Y)
0.28

Employees


Employees (FY)
110
Change (1Y)
+10 +10.00%
Revenue / Employee (1Y)
‪1.06 M‬ AUD
Net income / Employee (1Y)
‪84.81 K‬ AUD

About AFT PHARMACEUTICALS LTD NPV


Sector
Health Technology
CEO
Hartley Atkinson
Headquarters
Auckland
Website
aftpharm.com
Founded
1997
ISIN
NZAFTE0001S4
FIGI
BBG00BQXDKK3
AFT Pharmaceuticals Ltd. engages in the development, licensing, and distribution of medical and pharmaceutical products. It operates through the following geographical segments: Australia, New Zealand, Asia, and Rest of the World. The Australia segment caters to the Australian market. The New Zealand segment focuses on the head office function, supplier relationships and procurement of stock, and regulatory, marketing, and finance activities of the group. The Asia segment relates in the sales activities in Brunei, Hong Kong, Malaysia, Philippines, Singapore, and Vietnam markets. The Rest of the World segment consists of out licensing of internet protocol developments to markets in which the firm does not have a presence and the export of products to export markets. The company was founded by Hartley Atkinson and Marree Atkinson on September 4, 1997 and is headquartered in Auckland, New Zealand.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

AFP news



Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of AFP is 2.57 AUD — it has increased by 4.90% in the past 24 hours. Watch AFT PHARMACEUTICALS LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange AFT PHARMACEUTICALS LIMITED stocks are traded under the ticker AFP.
AFP stock has fallen by −6.55% compared to the previous week, the month change is a −13.18% fall, over the last year AFT PHARMACEUTICALS LIMITED has showed a −18.15% decrease.
We've gathered analysts' opinions on AFT PHARMACEUTICALS LIMITED future price: according to them, AFP price has a max estimate of 4.18 AUD and a min estimate of 2.41 AUD. Watch AFP chart and read a more detailed AFT PHARMACEUTICALS LIMITED stock forecast: see what analysts think of AFT PHARMACEUTICALS LIMITED and suggest that you do with its stocks.
AFP reached its all-time high on Nov 10, 2020 with the price of 5.25 AUD, and its all-time low was 1.90 AUD and was reached on Apr 24, 2019. View more price dynamics on AFP chart.
See other stocks reaching their highest and lowest prices.
AFP stock is 4.67% volatile and has beta coefficient of 0.28. Track AFT PHARMACEUTICALS LIMITED stock price on the chart and check out the list of the most volatile stocks — is AFT PHARMACEUTICALS LIMITED there?
Today AFT PHARMACEUTICALS LIMITED has the market capitalization of ‪252.89 M‬, it has decreased by −1.18% over the last week.
Yes, you can track AFT PHARMACEUTICALS LIMITED financials in yearly and quarterly reports right on TradingView.
AFT PHARMACEUTICALS LIMITED is going to release the next earnings report on Nov 20, 2024. Keep track of upcoming events with our Earnings Calendar.
AFT PHARMACEUTICALS LIMITED revenue for the last half-year amounts to ‪101.41 M‬ AUD, despite the estimated figure of ‪101.37 M‬ AUD. In the next half-year revenue is expected to reach ‪88.18 M‬ AUD.
AFP net income for the last half-year is ‪12.64 M‬ AUD, while the previous report showed ‪1.69 M‬ AUD of net income which accounts for 647.14% change. Track more AFT PHARMACEUTICALS LIMITED financial stats to get the full picture.
Yes, AFP dividends are paid annually. The last dividend per share was 0.01 AUD. As of today, Dividend Yield (TTM)% is 0.60%. Tracking AFT PHARMACEUTICALS LIMITED dividends might help you take more informed decisions.
AFT PHARMACEUTICALS LIMITED dividend yield was 0.51% in 2023, and payout ratio reached 10.75%. The year before the numbers were 0.32% and 10.83% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 11, 2024, the company has 110.00 employees. See our rating of the largest employees — is AFT PHARMACEUTICALS LIMITED on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. AFT PHARMACEUTICALS LIMITED EBITDA is ‪23.57 M‬ AUD, and current EBITDA margin is 13.16%. See more stats in AFT PHARMACEUTICALS LIMITED financial statements.
Like other stocks, AFP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade AFT PHARMACEUTICALS LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So AFT PHARMACEUTICALS LIMITED technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating AFT PHARMACEUTICALS LIMITED stock shows the strong sell signal. See more of AFT PHARMACEUTICALS LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.